Bioxytran, Inc.

Biotechnology • Healthcare • Needham, MA, United States • BIXT (OQB)

Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company's lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing. It is also developing ProLectin-Rx, a polysaccharide derived from pectin that binds to, and blocks the activity of galectin-1, a type of galectin for treatment of mild to moderate cases of Covid-19. The company was founded in 2008 and is headquartered in Needham, Massachusetts.

617 454 1199 75 2nd Avenue, Needham, MA 02494, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Bioxytran (OTCQB: BIXT) completes ProLectin‑M trial; data to guide CDSCO Phase 3 and FDA - Stock Titan

Stock Titan • Oct 29

Bioxytran (OTCQB: BIXT) director exit prompts audit and governance process review - Stock Titan

Stock Titan • Dec 15

Check out Bioxytran's stock price (BIXT) in real time - CNBC

CNBC • Apr 6

Galectin Therapeutics (GALT) A Discount Opportunity Moving on Analysts Upgrade - Insider Financial

Insider Financial • Apr 10

Bioxytran's Medical Breakthrough in Fighting All Viruses - Yahoo Finance

Yahoo Finance • Sep 19

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has BIOXYTRAN, INC had layoffs?

No layoff events have been recorded for BIOXYTRAN, INC in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is BIOXYTRAN, INC in?

BIOXYTRAN, INC operates in the Biotechnology industry, within the Healthcare sector.

Is BIOXYTRAN, INC a publicly traded company?

Yes, BIOXYTRAN, INC is publicly traded under the ticker symbol BIXT on the OQB. The company has a market capitalization of approximately $0.01 billion.

Where is BIOXYTRAN, INC headquartered?

BIOXYTRAN, INC is headquartered in Needham, MA, United States at 75 2nd Avenue, Needham, MA 02494, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.